“Pothead” could one day get a whole new meaning. A new study suggests low doses of THC, the main psychoactive ingredient in ...

Following the hard-won success of early anti-amyloid drugs, a new generation of Alzheimer’s modalities—from tau-targeting ...

Early in Alzheimer’s disease, your brain can begin to change long before anyone notices a lost name or missed appointment.

THC plus a common anti-inflammatory drug show promise.

In recent years, research into cannabis and its main psychoactive ingredient, Δ⁹-tetrahydrocannabinol (THC), has unearthed ...

By Athena VlachouDrugs used to treat metabolic disorders, such as Type 2 diabetes, alleviate symptoms of Alzheimer’s disease ...

Annovis is also seeking fresh capital while working to advance trials for both Alzheimer's and Parkinson's disease drugs.

Researchers analyzed Medicare claims data to find that an estimated 25 percent of dementia patients were prescribed risky medications, including antidepressants and antipsychotics.

Anavex (AVXL) blarcamesine faces uncertain FDA path in early Alzheimer’s; Phase 3 may be needed. Read here a detailed ...

From Science.org. "T3D Therapeutics alleges that contract researchers delivered “medically impossible” results on its candidate drug. In 2023, the drug ...

When the brain rests, it usually replays recent experiences to strengthen memory. Scientists found that in Alzheimer’s-like ...